Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson purchased 207 shares of Dr. Martens stock in a transaction that occurred on Tuesday, February 11th. The shares were bought at an average price of GBX 73 ($0.92) per share, for a total transaction of £151.11 ($190.10).
Giles Wilson also recently made the following trade(s):
- On Monday, January 13th, Giles Wilson acquired 222 shares of Dr. Martens stock. The shares were acquired at an average cost of GBX 68 ($0.86) per share, for a total transaction of £150.96 ($189.91).
Dr. Martens Stock Down 0.0 %
LON:DOCS traded down GBX 0.01 ($0.00) during mid-day trading on Friday, hitting GBX 72 ($0.91). 1,440,094 shares of the company's stock were exchanged, compared to its average volume of 1,754,873. Dr. Martens plc has a one year low of GBX 49.32 ($0.62) and a one year high of GBX 100 ($1.26). The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The business has a fifty day moving average price of GBX 72.34 and a 200 day moving average price of GBX 65.55. The company has a market cap of £698.90 million, a PE ratio of 10.21, a P/E/G ratio of 6.40 and a beta of 0.11.
Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, November 28th. The company reported GBX (1.30) (($0.02)) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The firm also recently disclosed a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, March 6th. Dr. Martens's payout ratio is currently 42.53%.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
